KovatchevBP: Metrics for glycaemic control—from HbA1c to continuous glucose monitoring. Nat Rev Endocrinol, 2017; 13:425–436.
2.
MolnarGD, TaylorWF, HoMM: Day-to-day variation of continuously monitored glycaemia: a further measure of diabetic instability. Diabetologia, 1972; 8:342–348.
3.
ServiceFJ, O'BrienPC, RizzaRA: Measurements of glucose control. Diabetes Care, 1987; 10:225–237.
4.
SiegelaarSE, HollemanF, HoekstraJB, et al.: Glucose variability; does it matter?. Endocr Rev, 2010; 31:171–182.
5.
KovatchevB, CobelliC: Glucose variability: timing, risk analysis, and relationship to hypoglycemia in diabetes. Diabetes Care, 2016; 39: 502–510.
6.
IuchiH, SakamotoM, MatsutaniD, et al.: The durability of basal insulin affects day-to-day glycemic variability assessed by continuous glucose monitoring in type 2 diabetes patients: a randomized crossover trial. Diabetes Technol Ther, 2017; 457–462.
7.
ZhouJ, JiaW, BaoY, et al.: Glycemic variability and its responses to intensive insulin treatment in newly diagnosed type 2 diabetes. Med Sci Monit, 2008; 14:CR552–CR558.
8.
XuF, ZhaoL-H, SuJ-B, et al.: The relationship between glycemic variability and diabetic peripheral neuropathy in type 2 diabetes with well-controlled HbA1c. Diabetol Metab Syndr, 2014; 6:139.
9.
OharaM, FukuiT, OuchiM, et al.: Relationship between daily and day-to-day glycemic variability and increased oxidative stress in type 2 diabetes. Diabetes Res Clin Pract, 2016; 122:62–70.
10.
JinS-M, KimT-H, BaeJC, et al.: Clinical factors associated with absolute and relative measures of glycemic variability determined by continuous glucose monitoring: an analysis of 480 subjects. Diabetes Res Clin Pract, 2014; 104:266–272.
BasuA, VeettilS, DyerR, et al.: Direct evidence of acetaminophen interference with subcutaneous glucose sensing in humans: a pilot study. Diabetes Technol Ther, 2016; 18Suppl 2:S243–S247.
13.
BasuA, SlamaMQ, NicholsonWT, et al.: Continuous glucose monitor interference with commonly prescribed medications. J Diabetes Sci Technol, 2017:1932296817697329.
14.
CarlsonAL, MullenDM, BergenstalRM: Clinical use of continuous glucose monitoring in adults with type 2 diabetes. Diabetes Technol Ther, 2017; 19:S4–S11.
15.
RodbardD: New and improved methods to characterize glycemic variability using continuous glucose monitoring. Diabetes Technol Ther, 2009; 11:551–565.
